You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

FINAFLOXACIN - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for finafloxacin and what is the scope of freedom to operate?

Finafloxacin is the generic ingredient in one branded drug marketed by Fonseca Biosciences and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Finafloxacin has forty-two patent family members in eighteen countries.

Summary for FINAFLOXACIN
International Patents:42
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 44
Clinical Trials: 7
Patent Applications: 178
DailyMed Link:FINAFLOXACIN at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for FINAFLOXACIN
Generic Entry Date for FINAFLOXACIN*:
Constraining patent/regulatory exclusivity:
Dosage:
SUSPENSION/DROPS;OTIC

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for FINAFLOXACIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
MerLion Pharmaceuticals GmbHPhase 2
MerLion Pharmaceuticals GmbHPhase 1

See all FINAFLOXACIN clinical trials

US Patents and Regulatory Information for FINAFLOXACIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fonseca Biosciences XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fonseca Biosciences XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fonseca Biosciences XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Fonseca Biosciences XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for FINAFLOXACIN

Country Patent Number Title Estimated Expiration
Japan 5980440 ⤷  Sign Up
Russian Federation 2693476 КОМПОЗИЦИИ ФИНАФЛОКСАЦИНА В ВИДЕ СУСПЕНЗИИ (FINAFLOXACIN SUSPENSION COMPOSITIONS) ⤷  Sign Up
China 104869999 Finafloxacin suspension compositions ⤷  Sign Up
Taiwan 201102395 Compositions and methods for treating ophthalmic, otic, or nasal infections ⤷  Sign Up
European Patent Office 2448587 COMPOSITIONS COMPRENANT DE LA FINAFLOXACINE ET MÉTHODES DE TRAITEMENT D'INFECTIONS OPHTALMIQUES, OTIQUES OU NASALES (COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS) ⤷  Sign Up
Japan 2012532115 ⤷  Sign Up
Japan 2015134827 眼、耳または鼻の感染症を処置するためのフィナフロキサシンを含む組成物および方法 (COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.